ADR — Adherium Share News
0.000.00%
- AU$3.27m
- AU$4.25m
- AU$3.19m
Brief: Adherium Says Placement And Entitlement Offer To Raise Up To A$8.37 Million
Brief: Adherium Seeks Trading Halt
Brief: Adherium Says Hailie Smartinhaler Got Clearance From U.S. FDA
Australia's Adherium climbs to 1-1/2-year high after US FDA approval
Brief: Adherium Secures Strategic Partnership Secured With Rimidi
Brief: Adherium And Alliance Tech Medical Partnership To Expand Product Reach In United States
Brief: Adherium Appoints Paul Mastoridis As CEO
Brief: Adherium Ltd Says Rick Legleiter Tendered Resignation As Chief Executive Officer
Brief: Adherium Partners With NuvoAir Medical To Enhance Patient Outcomes
Australia's Adherium rises as co completes first delivery of its smart inhaler
Brief: Adherium Announces New Major Asthma Partnership With US-Based Senta Partners
Brief: Adherium Signs Collaboration Agreement With Allergy Partners
Australia's Adherium jumps after FDA clearance for inhalers
Brief: Adherium Got U.S. FDA 510(K) Clearance For Teva's Proair & Albuterol Sulphate Inhaler
Brief: Adherium Posts HY Operating Revenue Of A$1.2 Million
Australia's Adherium hits 3-month high on approval for sensors
Brief: Adherium Says It Got TGA Approval To Commercially Distribute Hailie Sensors
Brief: Adherium Receives U.S. FDA Clearance For GSK PMDI Inhaler Users To Remotely Monitor Physiological Parameters
Brief: Adherium Appoints Daniel Kaplon As Chief Financial Officer